Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 10 | 2019 | 54 | 1.870 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2019 | 51 | 1.480 |
Why?
|
| Receptors, Thyroid Hormone | 8 | 2015 | 45 | 1.340 |
Why?
|
| Liver | 13 | 2026 | 1802 | 1.100 |
Why?
|
| Co-Repressor Proteins | 3 | 2015 | 38 | 0.930 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 1215 | 0.670 |
Why?
|
| Thyroid Gland | 4 | 2015 | 98 | 0.630 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2017 | 17 | 0.630 |
Why?
|
| Triiodothyronine | 5 | 2014 | 53 | 0.580 |
Why?
|
| Hypothyroidism | 4 | 2017 | 77 | 0.570 |
Why?
|
| Energy Metabolism | 4 | 2025 | 799 | 0.530 |
Why?
|
| Repressor Proteins | 4 | 2009 | 773 | 0.510 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2343 | 0.500 |
Why?
|
| Cholesterol | 4 | 2019 | 541 | 0.460 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2015 | 56 | 0.450 |
Why?
|
| Fructose | 3 | 2021 | 61 | 0.430 |
Why?
|
| Sulfotransferases | 3 | 2004 | 29 | 0.430 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 3 | 2019 | 6 | 0.350 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1380 | 0.340 |
Why?
|
| Hepatocytes | 3 | 2026 | 235 | 0.320 |
Why?
|
| Animals | 32 | 2026 | 33852 | 0.310 |
Why?
|
| Lipid Metabolism | 3 | 2025 | 373 | 0.310 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2025 | 199 | 0.290 |
Why?
|
| Mice, Knockout | 10 | 2026 | 3812 | 0.290 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2019 | 32 | 0.280 |
Why?
|
| Thyroxine | 4 | 2019 | 59 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 5 | 2025 | 1221 | 0.250 |
Why?
|
| Thyrotropin | 4 | 2019 | 50 | 0.240 |
Why?
|
| Mice | 20 | 2026 | 18180 | 0.240 |
Why?
|
| Protein Binding | 6 | 2015 | 1657 | 0.220 |
Why?
|
| Cell Communication | 1 | 2026 | 186 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2025 | 274 | 0.200 |
Why?
|
| Transcription Factors | 4 | 2025 | 2437 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 315 | 0.190 |
Why?
|
| Succinic Acid | 1 | 2022 | 14 | 0.190 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 57 | 0.180 |
Why?
|
| Liver X Receptors | 2 | 2014 | 14 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2014 | 19 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 13 | 0.180 |
Why?
|
| Triglycerides | 2 | 2021 | 605 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 58 | 0.170 |
Why?
|
| Introns | 1 | 2002 | 281 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2026 | 683 | 0.170 |
Why?
|
| Lipogenesis | 2 | 2018 | 62 | 0.170 |
Why?
|
| Metabolomics | 1 | 2025 | 502 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 171 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2026 | 4698 | 0.160 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 118 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.160 |
Why?
|
| Food Deprivation | 1 | 2020 | 33 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 146 | 0.150 |
Why?
|
| Exons | 1 | 2002 | 763 | 0.150 |
Why?
|
| Glucosides | 1 | 2020 | 54 | 0.150 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2019 | 10 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 76 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2017 | 4649 | 0.140 |
Why?
|
| Aging | 1 | 2026 | 1251 | 0.140 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2018 | 10 | 0.140 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Mutation | 5 | 2017 | 6129 | 0.140 |
Why?
|
| Insulin | 2 | 2021 | 1146 | 0.140 |
Why?
|
| Glucose | 1 | 2023 | 853 | 0.140 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 3 | 0.140 |
Why?
|
| Rats | 6 | 2025 | 3374 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1828 | 0.130 |
Why?
|
| Transcriptome | 1 | 2025 | 1130 | 0.130 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 74 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3487 | 0.120 |
Why?
|
| Pituitary Gland | 2 | 2014 | 75 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2019 | 1014 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2014 | 162 | 0.120 |
Why?
|
| Gene Expression | 2 | 2011 | 1488 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 137 | 0.110 |
Why?
|
| Body Weight | 1 | 2019 | 986 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2015 | 396 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 78 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 126 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 836 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 196 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 548 | 0.110 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 5 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2021 | 2553 | 0.110 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 14 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 50 | 0.100 |
Why?
|
| Models, Animal | 1 | 2015 | 455 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1454 | 0.100 |
Why?
|
| Lipids | 4 | 2023 | 562 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 714 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 696 | 0.100 |
Why?
|
| Regeneration | 1 | 2015 | 230 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 427 | 0.100 |
Why?
|
| Ligands | 2 | 2012 | 486 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 372 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 147 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 191 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 478 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 765 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 24 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2014 | 276 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2003 | 254 | 0.090 |
Why?
|
| Cell Line | 4 | 2015 | 2568 | 0.090 |
Why?
|
| Chromatin | 1 | 2015 | 502 | 0.090 |
Why?
|
| Male | 17 | 2026 | 64486 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 358 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 624 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2898 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 325 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2011 | 111 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1005 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 440 | 0.080 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2007 | 39 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 53 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 1949 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1917 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 60 | 0.070 |
Why?
|
| Base Sequence | 2 | 2003 | 2753 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 280 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1840 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 486 | 0.070 |
Why?
|
| Tosyl Compounds | 1 | 2007 | 22 | 0.070 |
Why?
|
| Humans | 14 | 2025 | 130403 | 0.070 |
Why?
|
| Anilides | 1 | 2007 | 50 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1395 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 161 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 2004 | 143 | 0.060 |
Why?
|
| Obesity | 1 | 2018 | 2383 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1603 | 0.060 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2026 | 35 | 0.060 |
Why?
|
| Hepatic Stellate Cells | 1 | 2026 | 30 | 0.060 |
Why?
|
| Acetylation | 2 | 2017 | 182 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 60 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1004 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 414 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2397 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2004 | 43 | 0.060 |
Why?
|
| Mifepristone | 1 | 2004 | 85 | 0.050 |
Why?
|
| Adipocytes | 1 | 2006 | 176 | 0.050 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 9 | 0.050 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 17 | 0.050 |
Why?
|
| Circadian Clocks | 1 | 2025 | 86 | 0.050 |
Why?
|
| Binding Sites | 2 | 2004 | 1143 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 52 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 15 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 96 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 1333 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2026 | 357 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 32 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 43 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1111 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2923 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 727 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2023 | 196 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 97 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 778 | 0.040 |
Why?
|
| Female | 9 | 2025 | 70343 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2002 | 360 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2002 | 310 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 522 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 77 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1398 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 143 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2015 | 562 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 384 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 58 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 198 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 715 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 25 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 588 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 60 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2343 | 0.030 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 59 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 22 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 301 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 301 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 528 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 931 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 381 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 323 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1723 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2846 | 0.030 |
Why?
|
| Bone Density | 1 | 2019 | 365 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2015 | 5 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 972 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 104 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 653 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 89 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 50 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 810 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 702 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1103 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 227 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 56 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4654 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 361 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 582 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 24 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 526 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 544 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1123 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 88 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 950 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 832 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2012 | 9 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 188 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5084 | 0.020 |
Why?
|
| Genes, erbA | 1 | 2011 | 1 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1569 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4475 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 214 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 770 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1315 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 96 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 521 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 89 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1211 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1003 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 360 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6773 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 225 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2006 | 54 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 968 | 0.010 |
Why?
|
| Calcitriol | 1 | 2006 | 64 | 0.010 |
Why?
|
| Androgens | 1 | 2007 | 267 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2006 | 229 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 70 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 491 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 661 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1283 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1387 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 20899 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20731 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 28395 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1788 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 31125 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3702 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6183 | 0.010 |
Why?
|